Showing results (201-210 of 424) with videos related to
Sort By:
Pageof 43
Contemporary Clinical Trials|November 16, 2019
A randomized, double-blind, multicenter, phase 2b study to evaluate the safety and efficacy of a combination of tropifexor and cenicriviroc in patients with nonalcoholic steatohepatitis and liver fibrosis: Study design of the TANDEM trialMarcos Pedrosa, Star Seyedkazemi, Sven Francque, et al.Hepatology (Baltimore, Md.)|January 25, 2022
Persistence of severe liver fibrosis despite substantial weight loss with bariatric surgeryRaluca Pais, Judith Aron-Wisnewsky, Pierre Bedossa, et al.Hepatology (Baltimore, Md.)|November 1, 2007
Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failureDominique Thabut, Julien Massard, Alice Gangloff, et al.Cancer|March 3, 2007
Gemcitabine plus oxaliplatin (GEMOX) in patients with advanced hepatocellular carcinoma (HCC): results of a phase II studySamy Louafi, Valérie Boige, Michel Ducreux, et al.BMC Gastroenterology|February 3, 2007
Invasive pulmonary aspergillosis in patients with decompensated cirrhosis: case seriesHélène Prodanovic, Christophe Cracco, Julien Massard, et al.Alimentary Pharmacology & Therapeutics|August 29, 2023
Prospective direct comparison of non-invasive liver tests in outpatients with type 2 diabetes using intention-to-diagnose analysisThierry Poynard, Olivier Deckmyn, Valentina Peta, et al.Biomedicines|December 30, 2025
An Invisible Early Steatosis Phenotype Defined for a Large Population-Based CohortThierry Poynard, Olivier Deckmyn, Valentina Peta, et al.Journal of Gastroenterology and Hepatology|November 30, 2012
Interferon-gamma with peginterferon alpha-2a and ribavirin in nonresponder patients with chronic hepatitis C (ANRS HC16 GAMMATRI)Patrice Couzigou, Sophie Pérusat, Marc Bourlière, et al.Journal of Hepatology|July 26, 2011
Influence of interferon-based therapy on liver fibrosis progression in HIV/HCV coinfected patients: a retrospective repeated liver biopsy analysisPatrick Ingiliz, Marc-Antoine Valantin, Paul Preziosi, et al.Journal of Hepatology|March 31, 2023
A proposal from the liver forum for the management of comorbidities in non-alcoholic steatohepatitis therapeutic trialsRaluca Pais, Bertrand Cariou, Mazen Noureddin, et al.Pageof 43